The neuropathology of CDKL5 disorder

Awardee: Delia Talos

Institution: University of Pennsylvania SOM

Award Amount: $51,160

Funding Period: January 1, 2018 - December 31, 2018

Previous
Previous

Pilot study to identify small molecule activators of TCF4 as a treatment for Pitt-Hopkins syndrome

Next
Next

Neuronal determinants of CDKL5 deficiency disorder: neuropathological, genetic and molecular analysis of postmortem brains